A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer
Clinical trial NCT00952497 · COMPLETED
Trial details
- NCT number
- NCT00952497
- Sponsor
- ACT Biotech, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-10-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.